Search Results - "Spies, Petra E"

Refine Results
  1. 1

    Does a bicycle accident as the cause of proximal femur fracture indicate that geriatric co-management is superfluous? A retrospective cohort study by Spies, Petra E, Fix, Malene, Emmink, Benjamin L, Schermer, Tjard R

    “…Deployment of geriatric care would be more sustainable if we could limit geriatric co-management to older hip fracture patients who benefit most from it. We…”
    Get full text
    Journal Article
  2. 2

    Prescriptions of newer glucose regulating agents in older hospitalized patients with type 2 diabetes A retrospective cohort study by Janssen, Drs. Merel L.J.M., van der Linden, Dr. Carolien M.J., Deenen, Dr. Maarten J., Spies, Dr. Petra E., Jacobs, Drs. Anne

    Published in Diabetes epidemiology and management (01-10-2023)
    “…•The prescription prevalence of newer GRA in clinical admissions of older patients (≥70 years) increased from 2017 to 2021.•The prescription prevalence was…”
    Get full text
    Journal Article
  3. 3

    Alzheimer biomarkers and clinical Alzheimer disease were not associated with increased cerebrovascular disease in a memory clinic population by Spies, Petra E, Verbeek, Marcel M, Sjogren, Magnus J C, de Leeuw, Frank-Erik, Claassen, Jurgen A H R

    Published in Current Alzheimer research (01-01-2014)
    “…Preclinical and post-mortem studies suggest that Alzheimer disease (AD) causes cerebrovascular dysfunction, and therefore may enhance susceptibility to…”
    Get more information
    Journal Article
  4. 4

    The Comparative Risk of Delirium with Different Opioids: A Systematic Review by Swart, Lieke M., van der Zanden, Vera, Spies, Petra E., de Rooij, Sophia E., van Munster, Barbara C.

    Published in Drugs & aging (01-06-2017)
    “…Objective There is substantial evidence that the use of opioids increases the risk of adverse outcomes such as delirium, but whether this risk differs between…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8

    Orthostatic blood pressure recovery in older males using alpha‐blockers for lower urinary tract symptoms, an explorative study in a urology outpatient clinic by Spies, Petra E., Beune, Thimpe N. N., Heesakkers, John, Munster, Barbara C., Claassen, Jurgen A. H. R.

    “…What is known and objective Alpha‐blockers have been associated with orthostatic hypotension (OH). We aimed to assess the prevalence of OH measured with…”
    Get full text
    Journal Article
  9. 9

    The predictive value of the ‘VMS frail older patients’ for adverse outcomes in geriatric inpatients by Oud, Frederike M.M., Wolzak, Nena K., Spies, Petra E., Zaag-Loonen, H.J. van der, van Munster, Barbara C.

    Published in Archives of gerontology and geriatrics (01-11-2021)
    “…•Almost all geriatric inpatients scored positive on the ‘VMS frail older patients’.•A VMS score of ≥1 had no predictive value for adverse outcomes.•The total…”
    Get full text
    Journal Article
  10. 10

    Cerebrospinal fluid alpha-synuclein does not discriminate between dementia disorders by Spies, Petra E, Melis, René J F, Sjögren, Magnus J C, Rikkert, Marcel G M Olde, Verbeek, Marcel M

    Published in Journal of Alzheimer's disease (01-01-2009)
    “…Alpha-synuclein is the major constituent of Lewy bodies found in neurons in dementia with Lewy bodies (DLB) and might be of diagnostic value as a biomarker for…”
    Get more information
    Journal Article
  11. 11

    Hourly variability of cerebrospinal fluid biomarkers in Alzheimer's disease subjects and healthy older volunteers by Slats, Diane, Claassen, Jurgen A.H.R, Spies, Petra E, Borm, George, Besse, Kees T.C, van Aalst, William, Tseng, Jack, Sjögren, Magnus J.C, Olde Rikkert, Marcel G.M, Verbeek, Marcel M

    Published in Neurobiology of aging (01-04-2012)
    “…Abstract Large hour-to-hour variability has previously been demonstrated in the cerebrospinal fluid (CSF) concentrations of Alzheimer's disease (AD) biomarkers…”
    Get full text
    Journal Article
  12. 12

    Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias by Herbert, Megan K, Aerts, Marjolein B, Kuiperij, H. Bea, Claassen, Jurgen A.H.R, Spies, Petra E, Esselink, Rianne A.J, Bloem, Bastiaan R, Verbeek, Marcel M

    Published in Alzheimer's & dementia (01-07-2014)
    “…Abstract Background Overlapping clinical features make it difficult to distinguish dementia with Lewy bodies (DLB) from Alzheimer's disease (AD) and other…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer’s Disease in Clinical Practice: An Illustration with 3 Case Reports by Slats, Diane, Spies, Petra E., Sjögren, Magnus J.C., Verhey, Frans R.J., Verbeek, Marcel M., Olde Rikkert, Marcel G.M.

    Published in Case reports in neurology (24-02-2010)
    “…Analysis of the brain specific biomarkers amyloid β 42 (Aβ 42 ) and total tau (t-tau) protein in cerebrospinal fluid (CSF) has a sensitivity and specificity of…”
    Get full text
    Journal Article
  15. 15

    Reviewing reasons for the decreased CSF Abeta42 concentration in Alzheimer disease by Spies, Petra E, Verbeek, Marcel M, van Groen, Thomas, Claassen, Jurgen A H R

    Published in Frontiers in bioscience (Landmark. Print) (01-06-2012)
    “…Cerebrospinal fluid (CSF) amyloid beta42 (Abeta42) concentrations are decreased in patients with Alzheimer disease (AD). Consequently, low Abeta42 is…”
    Get more information
    Journal Article
  16. 16

    A prediction model to calculate probability of Alzheimer’s disease using cerebrospinal fluid biomarkers by Spies, Petra E, Claassen, Jurgen A.H.R, Peer, Petronella G.M, Blankenstein, Marinus A, Teunissen, Charlotte E, Scheltens, Philip, van der Flier, Wiesje M, Olde Rikkert, Marcel G.M, Verbeek, Marcel M

    Published in Alzheimer's & dementia (01-05-2013)
    “…Abstract Background We aimed to develop a prediction model based on cerebrospinal fluid (CSF) biomarkers, that would yield a single estimate representing the…”
    Get full text
    Journal Article
  17. 17
  18. 18

    CSF α-synuclein concentrations do not fluctuate over hours and are not correlated to amyloid β in humans by Spies, Petra E., Slats, Diane, Olde Rikkert, Marcel G.M., Tseng, Jack, Claassen, Jurgen A.H.R., Verbeek, Marcel M.

    Published in Neuroscience letters (31-10-2011)
    “…► CSF α-synuclein concentrations do not display sinusoidal fluctuations. ► An interaction between Aβ and α-synuclein is not observed in their CSF…”
    Get full text
    Journal Article
  19. 19

    Interaction between tramadol and selective serotonin reuptake inhibitors: are doctors aware of potential risks in their prescription practice? by Spies, Petra E, Pot, J L W (Hans), Willems, Roel P J, Bos, Jacqueline M, Kramers, Cornelis

    “…ObjectivesThe combination of a selective serotonin reuptake inhibitor (SSRI) or serotonin–norepinephrine reuptake inhibitor (SNRI) with tramadol can result in…”
    Get full text
    Journal Article
  20. 20

    Geriatrische revalidatiezorg na triage op de Spoedeisende Hulp: Patiëntkarakteristieken en revalidatie-uitkomsten by Stephanie van Zuilekom, Renate M. Schut, Barbara C. van Munster, Petra E. Spies

    Published in Tijdschrift voor gerontologie en geriatrie (01-03-2019)
    “…Geriatrische revalidatiezorg (GRZ) is in Nederland ook mogelijk na triage door de klinisch geriater op de Spoedeisende Hulp (SEH). Het doel van deze studie is…”
    Get full text
    Journal Article